Company news

Share this article:
Cypress Pharmaceutical has entered into a multiple generic product development and marketing agreement with Standard Chem. & Pharm. Under the terms of the deal, Standard Chem. & Pharm. has the exclusive development and manufacturing rights and Cypress Pharmaceutical, Inc. has exclusive US marketing rights of generic drug products. Other financial terms of the agreement have not been disclosed.
Share this article:
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.